The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Latest results of a phase 2 study of IMM01 combined with azacitidine (AZA) as the first-line treatment in adults with higher risk myelodysplastic syndromes (MDS).
 
Wei Yang
No Relationships to Disclose
 
Sujun Gao
No Relationships to Disclose
 
Xiaojing Yan
No Relationships to Disclose
 
Rong Guo
No Relationships to Disclose
 
Lijie Han
No Relationships to Disclose
 
Fei Li
No Relationships to Disclose
 
Yafei Wang
No Relationships to Disclose
 
Junmin Li
No Relationships to Disclose
 
Chunkang Chang
No Relationships to Disclose
 
Haiping Yang
No Relationships to Disclose
 
Ronghua Hu
No Relationships to Disclose
 
Hongyan Tong
No Relationships to Disclose
 
Xingli Zhao
No Relationships to Disclose
 
Qiubai Li
No Relationships to Disclose
 
Jingdong Zhang
No Relationships to Disclose
 
Xin Du
No Relationships to Disclose
 
Zheng Dong
Employment - ImmuneOnco Biopharmaceuticals
Honoraria - ImmuneOnco Biopharmaceuticals
Research Funding - ImmuneOnco Biopharmaceuticals
 
Qiying Lu
Employment - ImmuneOnco Biopharmaceuticals
Leadership - ImmuneOnco Biopharmaceuticals
Stock and Other Ownership Interests - ImmuneOnco Biopharmaceuticals
Honoraria - ImmuneOnco Biopharmaceuticals
Research Funding - ImmuneOnco Biopharmaceuticals
 
Wenzhi Tian
Employment - ImmuneOnco Biopharmaceuticals
Leadership - ImmuneOnco Biopharmaceuticals
Stock and Other Ownership Interests - ImmuneOnco Biopharmaceuticals
Honoraria - ImmuneOnco Biopharmaceuticals
Research Funding - ImmuneOnco Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - ImmuneOnco Biopharmaceuticals
 
Zhi-Jian Xiao
No Relationships to Disclose